Metagenomi, Inc. (MGX)
NASDAQ: MGX · IEX Real-Time Price · USD
4.760
-0.010 (-0.21%)
At close: Jul 19, 2024, 4:00 PM
4.780
+0.020 (0.42%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Metagenomi Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Metagenomi stock have an average target of 17.83, with a low estimate of 6.00 and a high estimate of 25. The average target predicts an increase of 274.58% from the current stock price of 4.76.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Metagenomi stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 |
| Buy | 4 | 4 | 3 | 3 | 3 |
| Hold | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +110.08% | Jul 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +110.08% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +110.08% | May 7, 2024 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $16 → $6 | Buy → Hold | Downgrades | $16 → $6 | +26.05% | May 2, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +341.18% | Mar 28, 2024 |
Financial Forecast
Revenue This Year
39.66M
from 44.76M
Decreased by -11.40%
Revenue Next Year
26.62M
from 39.66M
Decreased by -32.88%
EPS This Year
-3.38
from -20.05
EPS Next Year
-3.45
from -3.38
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 60.9M | 46.2M | 31.5M |
| Avg | 39.7M | 26.6M | 19.1M |
| Low | 29.4M | 9.8M | 9.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 36.1% | 16.5% | 18.3% |
| Avg | -11.4% | -32.9% | -28.2% |
| Low | -34.3% | -75.3% | -63.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.05 | -2.75 | -2.31 |
| Avg | -3.38 | -3.45 | -3.10 |
| Low | -3.90 | -4.04 | -3.44 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.